<DOC>
	<DOCNO>NCT00751361</DOCNO>
	<brief_summary>Purpose evaluate Rheopheresis treatment patient high-risk dry age-related macular degeneration therapeutic alternative . Rheopheresis method therapeutic apheresis use methodology double filtration plasmapheresis treat microcirculatory disorder .</brief_summary>
	<brief_title>Dry Age-Related Macular Degeneration ( AMD ) Treatment With Rheopheresis Trial</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>50 85 year old diagnosis AMD eye must dry AMD study eye Study eye bestcorrected ETDRSvisual acuity 0.10.8 peripheral vein allow vascular access establish extracorporal circuit . retinal choroidal disorder AMD optic nerve disease , glaucoma condition limit view fundus acute bleeding eye General exclusion criterion treatment Rheopheresis : anaemia haemorrhagic diathesis coagulopathy diabetes serious acute chronic kidney liver failure hypotension systolic &lt; 100 mmHg chronic viral infection ( HIV , hepatitis B , C ) epilepsia , psychosis dementia malignant disease condition life expectancy &lt; 12 month know history alcohol drug abuse long term serious nicotine abuse</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Rheopheresis</keyword>
	<keyword>Dry Age Related Macular Degeneration</keyword>
	<keyword>AMD</keyword>
	<keyword>apheresis</keyword>
	<keyword>microcirculation</keyword>
</DOC>